Detection and Validation of Organic Metabolites in Urine for Clear Cell Renal Cell Carcinoma Diagnosis
This study highlights the feasibility of using urine as a reliable biospecimen for identifying VOC biomarkers in ccRCC. While further validation in larger cohorts is necessary, this study's capability to differentiate between ccRCC and control groups, despite sample size limitations, holds significant promise.
Authors
- Wen‐Yee Lee (ORCID: https://orcid.org/0000-0002-1568-5546)
- Kiana L. Holbrook (ORCID: https://orcid.org/0000-0001-8018-2091)
- George E. Quaye (ORCID: https://orcid.org/0000-0001-7020-2116)
- Xiaogang Su (ORCID: https://orcid.org/0000-0002-9642-9412)
- Ryan M. Young (ORCID: https://orcid.org/0000-0003-0706-8019)
- Elizabeth Noriega Landa (ORCID: https://orcid.org/0000-0002-5178-2909)
- Sabur Badmos
- Ahsan Habib (ORCID: https://orcid.org/0000-0003-3563-4276)
- Qin Gao (ORCID: https://orcid.org/0000-0003-0393-2252)
- Heinric Williams
- Angelica A. Chacon
Institutions
- Geisinger Medical Center (US)
- Children's Mercy Hospital (US)
- The University of Texas at El Paso (US)
- Gilead Sciences (United States) (US)
Publication Details
- Journal
- Metabolites
- Published
- 2024-10-13
- DOI
- https://doi.org/10.3390/metabo14100546
- Citations
- 10
- Primary Topic
- Advanced Chemical Sensor Technologies
- Type
- article
- Field-Weighted Citation Impact
- 1.84
Funders
- National Institutes of Health
- National Cancer Institute